Holding types
Countries
Sectors
Analyst ratings
Market Data
Dividend
Posts updated corporate presentation to website Reminder: Conference call to be held on August 19 th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) highlights its low-CapEx plan for growing revenue in an updated corporate presentation now available at www.evomemedical.com/investor.
SHIRLEY, N.Y., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today reported financial results for the second quarter ended June 30, 2024, featuring $421,000 in positive Adjusted EBITDA1, a reduction in debt, financial performance momentum and significant progress with its restructuring. The Company's financial statements for the three and six months ended June 30, 2024 and 2023 and related Management's Discussion and Analysis (MD&A) are available under the Company's profile on SEDAR+ (www.sedarplus.com).
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue at its core business unit, Biodex Medical Systems, Inc. (“Biodex”), while reducing total debt significantly for the third straight quarter.
Copper prices are increasing, driven by optimism about improving economic conditions in China.
Critical mineral reliance is paramount when it comes to putting more electrical vehicles (EVs) on the road, and thus, more countries are relying on data collaboration, which should generate interest in the Invesco Electric Vehicle Metals Commodity Strategy No K-1 ETF (EVMT).
FAQ
- What is EVMT ETF?
- Does EVMT pay dividends?
- What stocks are in EVMT ETF?
- What is the current assets under management for EVMT?
- What is EVMT average volume?
- What is EVMT expense ratio?
- What is EVMT inception date?